ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
Akinjiyan FA, Nassief G, Phillipps J, Adeyelu T, Elliott A, Abdulla F, Zhou AY, Souroullas G, Kim KB, Vanderwalde A, Park SJ, Ansstas G.
Akinjiyan FA, et al. Among authors: abdulla f.
Sci Rep. 2024 Feb 11;14(1):3444. doi: 10.1038/s41598-024-54136-3.
Sci Rep. 2024.
PMID: 38341515
Free PMC article.